These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26106620)

  • 1. Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment.
    Martínez-Torteya A; Treviño V; Tamez-Peña JG
    Biomed Res Int; 2015; 2015():961314. PubMed ID: 26106620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Random forest feature selection, fusion and ensemble strategy: Combining multiple morphological MRI measures to discriminate among healhy elderly, MCI, cMCI and alzheimer's disease patients: From the alzheimer's disease neuroimaging initiative (ADNI) database.
    Dimitriadis SI; Liparas D; Tsolaki MN;
    J Neurosci Methods; 2018 May; 302():14-23. PubMed ID: 29269320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ensemble of random forests One vs. Rest classifiers for MCI and AD prediction using ANOVA cortical and subcortical feature selection and partial least squares.
    Ramírez J; Górriz JM; Ortiz A; Martínez-Murcia FJ; Segovia F; Salas-Gonzalez D; Castillo-Barnes D; Illán IA; Puntonet CG;
    J Neurosci Methods; 2018 May; 302():47-57. PubMed ID: 29242123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of Alzheimer's disease and prediction of mild cognitive impairment-to-Alzheimer's conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm.
    Beheshti I; Demirel H; Matsuda H;
    Comput Biol Med; 2017 Apr; 83():109-119. PubMed ID: 28260614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
    Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L;
    Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ensemble learning system for a 4-way classification of Alzheimer's disease and mild cognitive impairment.
    Yao D; Calhoun VD; Fu Z; Du Y; Sui J
    J Neurosci Methods; 2018 May; 302():75-81. PubMed ID: 29578038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
    Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
    Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative Sparse Features for Alzheimer's Disease Diagnosis Using Multimodal Image Data.
    Ortiz A; Lozano F; Gorriz JM; Ramirez J; Martinez Murcia FJ;
    Curr Alzheimer Res; 2018; 15(1):67-79. PubMed ID: 28934923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Alzheimer's Disease Classification by Combining Multiple Measures.
    Liu J; Wang J; Tang Z; Hu B; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(5):1649-1659. PubMed ID: 28749356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative multi-task feature selection for multi-modality classification of Alzheimer's disease.
    Ye T; Zu C; Jie B; Shen D; Zhang D;
    Brain Imaging Behav; 2016 Sep; 10(3):739-49. PubMed ID: 26311394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI Radiomics Classification and Prediction in Alzheimer's Disease and Mild Cognitive Impairment: A Review.
    Feng Q; Ding Z
    Curr Alzheimer Res; 2020; 17(3):297-309. PubMed ID: 32124697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Modality Cascaded Convolutional Neural Networks for Alzheimer's Disease Diagnosis.
    Liu M; Cheng D; Wang K; Wang Y;
    Neuroinformatics; 2018 Oct; 16(3-4):295-308. PubMed ID: 29572601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Role of Neuroimaging Markers for Early Diagnosis of Dementia in Primary Care.
    Teipel S; Kilimann I; Thyrian JR; Kloppel S; Hoffmann W
    Curr Alzheimer Res; 2018; 15(1):18-27. PubMed ID: 28891447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-modal discriminative dictionary learning for Alzheimer's disease and mild cognitive impairment.
    Li Q; Wu X; Xu L; Chen K; Yao L; Li R
    Comput Methods Programs Biomed; 2017 Oct; 150():1-8. PubMed ID: 28859825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pineal volume reduction in patients with mild cognitive impairment who converted to Alzheimer's disease.
    Matsuoka T; Oya N; Yokota H; Akazawa K; Yamada K; Narumoto J;
    Psychiatry Clin Neurosci; 2020 Nov; 74(11):587-593. PubMed ID: 32609399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's Disease Classification Based on Individual Hierarchical Networks Constructed With 3-D Texture Features.
    Liu J; Wang J; Hu B; Wu FX; Pan Y
    IEEE Trans Nanobioscience; 2017 Sep; 16(6):428-437. PubMed ID: 28541903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of patients with MCI and AD from healthy controls using directed graph measures of resting-state fMRI.
    Khazaee A; Ebrahimzadeh A; Babajani-Feremi A;
    Behav Brain Res; 2017 Mar; 322(Pt B):339-350. PubMed ID: 27345822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.